Risk Measurement of Perinatal and Neonatal Morbidity Characteristics and Applicability of GAIA Case Definitions: Results and Lessons Learnt of a Hospital-Based Prospective Cohort Study in the Valencia Region (2019-2020)


Por: Carmona A, Latorre Tejerina M, Martínez Sebastián A, Dobreva D, Jurca CP, Huerta Barberá S, Bernat Montoya V, Aristoy Zabaleta M, Pineda Caplliure A, Mansilla Roig B, Navío Anaya M, Tosca-Segura R, Tortajada-Girbés M, Díez-Domingo J and Orrico-Sánchez A

Publicada: 1 jun 2022 Ahead of Print: 10 jun 2022
Resumen:
Post-marketing safety surveillance of new vaccines aimed to be administered during pregnancy is crucial to orchestrate efficient adverse events evaluation. This is of special relevance in the current landscape of new vaccines being introduced in the pregnant women population, and particularly due to the recent administration of COVID-19 vaccines in pregnant women. This multi-center prospective cohort study, nested within the WHO-Global Vaccine Safety-MCC study, involved two hospitals in the Valencia region. Hereby, the incidence rates of seven perinatal and neonatal outcomes in the Valencia region are presented. The pooled data analysis of the two Valencian hospitals allowed the estimation of incidence rates in the Valencia Region (per 1000 live births): 86.7 for low birth weight, 78.2 for preterm birth, 58.8 for small for gestational age, 13 for congenital microcephaly, 0.4 for stillbirth, 1.2 for neonatal death and 6.5 for neonatal infection. These figures are in line with what is expected from a high-income country and the previously reported rates for Spain and Europe, except for the significantly increased rate for congenital microcephaly. Regarding the data for maternal immunization, the vaccination status was collected for 94.4% of the screened pregnant women, highlighting the high quality of the Valencian Vaccine Registry. The study also assessed the Valencian hospitals' capacity for identifying and collecting data on maternal immunization status, as well as the applicability of the GAIA definitions to the identified outcomes.

Filiaciones:
:
 Vaccines Research Department, Fundación Para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (Fisabio), Av. de Catalunya, 21, 46020 Valencia, Spain

:
 Department of Pediatrics, Hospital General Universitario de Castellón, Avinguda de Benicàssim, 128, 12004 Castelló de la Plana, Spain

:
 Department of Pediatrics, Hospital Universitario Doctor Peset, Av. de Gaspar Aguilar, 90, 46017 Valencia, Spain

Dobreva D:
 P95 Pharmacovigilance and Epidemiology, 3010 Leuven, Belgium

Jurca CP:
 Department of Pediatrics, Hospital General Universitario de Castellón, Avinguda de Benicàssim, 128, 12004 Castelló de la Plana, Spain

:
 Department of Pediatrics, Hospital General Universitario de Castellón, Avinguda de Benicàssim, 128, 12004 Castelló de la Plana, Spain

:
 Department of Pediatrics, Hospital General Universitario de Castellón, Avinguda de Benicàssim, 128, 12004 Castelló de la Plana, Spain

:
 Department of Pediatrics, Hospital General Universitario de Castellón, Avinguda de Benicàssim, 128, 12004 Castelló de la Plana, Spain

:
 Department of Pediatrics, Hospital Universitario Doctor Peset, Av. de Gaspar Aguilar, 90, 46017 Valencia, Spain

:
 Department of Pediatrics, Hospital Universitario Doctor Peset, Av. de Gaspar Aguilar, 90, 46017 Valencia, Spain

:
 Department of Pediatrics, Hospital Universitario Doctor Peset, Av. de Gaspar Aguilar, 90, 46017 Valencia, Spain

:
 Department of Pediatrics, Hospital General Universitario de Castellón, Avinguda de Benicàssim, 128, 12004 Castelló de la Plana, Spain

:
 Department of Pediatrics, Hospital Universitario Doctor Peset, Av. de Gaspar Aguilar, 90, 46017 Valencia, Spain

:
 Vaccines Research Department, Fundación Para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (Fisabio), Av. de Catalunya, 21, 46020 Valencia, Spain

 Universidad Católica de Valencia San Vicente Mártir, Carrer de Quevedo, 2, 46001 Valencia, Spain

:
 Vaccines Research Department, Fundación Para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (Fisabio), Av. de Catalunya, 21, 46020 Valencia, Spain

 Universidad Católica de Valencia San Vicente Mártir, Carrer de Quevedo, 2, 46001 Valencia, Spain
ISSN: 16617827





INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
Editorial
MDPI AG, POSTFACH, CH-4005 BASEL, SWITZERLAND, Suiza
Tipo de documento: Article
Volumen: 19 Número: 12
Páginas:
WOS Id: 000819614800001
ID de PubMed: 35742384
imagen gold, Green Published

FULL TEXT

imagen Published Version CC BY 4.0

MÉTRICAS